Zevra Therapeutics, Inc. (ZVRA)
12.04
+0.39
(+3.35%)
USD |
NASDAQ |
Aug 25, 16:00
12.05
+0.01
(+0.08%)
After-Hours: 19:59
Zevra Therapeutics Total Return Level : 12.04 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 12.04 |
| August 24, 2026 | 11.65 |
| August 21, 2026 | 11.87 |
| August 20, 2026 | 11.89 |
| August 19, 2026 | 12.13 |
| August 18, 2026 | 11.57 |
| August 17, 2026 | 11.53 |
| August 14, 2026 | 11.32 |
| August 13, 2026 | 11.18 |
| August 12, 2026 | 11.44 |
| August 11, 2026 | 11.34 |
| August 10, 2026 | 11.48 |
| August 07, 2026 | 11.56 |
| August 06, 2026 | 11.88 |
| August 05, 2026 | 10.53 |
| August 04, 2026 | 10.52 |
| August 03, 2026 | 10.06 |
| July 31, 2026 | 9.51 |
| July 30, 2026 | 9.64 |
| July 29, 2026 | 9.78 |
| July 28, 2026 | 9.73 |
| July 27, 2026 | 9.71 |
| July 24, 2026 | 9.525 |
| July 23, 2026 | 12.52 |
| July 22, 2026 | 12.14 |
| Date | Value |
|---|---|
| July 21, 2026 | 12.45 |
| July 20, 2026 | 12.03 |
| July 17, 2026 | 12.77 |
| July 16, 2026 | 12.76 |
| July 15, 2026 | 12.96 |
| July 14, 2026 | 13.06 |
| July 13, 2026 | 13.18 |
| July 10, 2026 | 13.35 |
| July 09, 2026 | 13.94 |
| July 08, 2026 | 14.75 |
| July 07, 2026 | 14.44 |
| July 06, 2026 | 13.97 |
| July 02, 2026 | 13.98 |
| July 01, 2026 | 13.81 |
| June 30, 2026 | 14.34 |
| June 29, 2026 | 14.01 |
| June 26, 2026 | 13.52 |
| June 25, 2026 | 13.23 |
| June 24, 2026 | 13.08 |
| June 23, 2026 | 13.00 |
| June 22, 2026 | 12.65 |
| June 18, 2026 | 12.90 |
| June 17, 2026 | 12.61 |
| June 16, 2026 | 12.65 |
| June 15, 2026 | 12.55 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Innoviva, Inc. | 22.77 |
| Collegium Pharmaceutical, Inc. | 27.47 |
| Johnson & Johnson | 651.77 |
| Ligand Pharmaceuticals, Inc. | 374.88 |
| Harrow, Inc. | 41.33 |